top selling glp-1 drugs Pharma's Top-Selling in Q1 2025: Oncology, Immunology, and | Pharmint posted on the topic Market Overview: GLP-1 Agonists and

Description

Some patients with Type 1 diabetes or advanced Type 2 diabetes use both a basal insulin like Toujeo and a rapid-acting insulin at meals, a regimen known as basal-bolus therapy

Clinical studies (in both obesity and type 2 diabetes) consistently show that GLP-1 RA treatment leads to less hunger, increased satiety, and spontaneous decreases in daily caloric consumption (Zheng et al., 2024)

The typical initiation regimen begins with 3 mg once daily for 30 days, primarily to improve gastrointestinal tolerability rather than for glycemic efficacy

As newer formulations reduce traditional barriers, clinicians are beginning to rethink when to initiate Read More Navigating Oral GLP-1s: When to Choose Pills Over Injections Feb 19, 2026 Articles, Diabetes, Therapies, Type 2 Diabetes, Type 2 Diabetes 3,183 views Oral GLP-1 therapy is quickly reshaping how we treat type 2 diabetes, especially for patients who hesitate at the thought of injections

Expert Viewpoint: Recovery Is the Training Variable You Control Most Two years of training clients on GLP-1 medications has taught me something that applies far beyond Ozempic users